General Information of Drug Transporter (DT)
DT ID DTD0254 Transporter Info
Gene Name SLC2A12
Transporter Name Glucose transporter type 12
Gene ID
154091
UniProt ID
Q8TD20
Post-Translational Modification of This DT
Overview of SLC2A12 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-O-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

371

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC2A12 Asparagine 371 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

383

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC2A12 Asparagine 383 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

396

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC2A12 Asparagine 396 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

401

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC2A12 Asparagine 401 has the potential to affect its expression or activity.

O-glycosylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

434

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC2A12 Serine 434 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

432

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC2A12 Threonine 432 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

433

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC2A12 Threonine 433 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A12 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

445

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC2A12 Threonine 445 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

220

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Serine 220 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A12 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

244

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Serine 244 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A12 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

264

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Serine 264 has the potential to affect its expression or activity.

  Threonine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

18

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Threonine 18 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A12 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

246

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Threonine 246 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A12 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

247

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Threonine 247 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC2A12 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

284

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Threonine 284 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC2A12 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

292

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Threonine 292 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC2A12 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Threonine 303 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

263

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Tyrosine 263 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A12 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

300

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A12 Tyrosine 300 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A12 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

235

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A12 Lysine 235 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A12 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

254

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A12 Lysine 254 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A12 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

258

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A12 Lysine 258 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR12_HUMAN)
2 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
3 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
4 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
5 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
7 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
8 Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin. PLoS One. 2014 Jan 6;9(1):e84488.
9 Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol. 2012 Oct;14(10):1089-98.
10 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.